MATTHEW M WALSH Insider Trading $AGN Allergan plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW M WALSH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW M WALSH. MATTHEW M WALSH is Director in MULTI COLOR Corp ($LABL) and in GENTEK INC ($GNKIQ) and VP, CFO & Asst. Treasurer in GENTEK INC ($GNKIQ) and EVP, Chief Financial Officer in Allergan plc ($AGN) and EVP & Chief Financial Officer in Catalent, Inc. ($CTLT) and See Remarks in Catalent, Inc. ($CTLT) and Director in Certara, Inc. ($CERT).
MATTHEW M WALSH in Allergan plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW M WALSH: EVP, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2020
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW M WALSH in Allergan plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, CTLT, CERT, GNKIQ, LABL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Option Exercise | D | 0.00 | 28,021 | 0 | 0 | |
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Option Exercise | D | 0.00 | 28,021 | 0 | 0 | |
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 27,618 | 0 | 0 | 27.6 K to 0 (-100.00 %) |
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 27,618 | 0 | 0 | 27.6 K to 0 (-100.00 %) |
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 12,039 | 0 | 0 | 12 K to 0 (-100.00 %) |
| May 11 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Sell | D | 0.00 | 12,039 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Mar 04 2020 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Grant | A | 193.84 | 15,476 | 2,999,868 | 39,657 | 24.2 K to 39.7 K (+64.00 %) |
| Feb 21 2019 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Payment of Exercise | F | 140.33 | 2,235 | 313,638 | 24,181 | 26.4 K to 24.2 K (-8.46 %) |
| Nov 19 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Buy | P | 157.00 | 1,000 | 157,000 | 26,416 | 25.4 K to 26.4 K (+3.93 %) |
| Mar 08 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Buy | P | 153.96 | 1,000 | 153,960 | 25,416 | 24.4 K to 25.4 K (+4.10 %) |
| Feb 22 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 28,021 | 0 | 28,021 | |
| Feb 22 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Buy | P | 160.94 | 2,000 | 321,880 | 24,416 | 22.4 K to 24.4 K (+8.92 %) |
| Feb 22 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Grant | A | 160.59 | 9,340 | 1,499,911 | 22,416 | 13.1 K to 22.4 K (+71.43 %) |
| Feb 22 2018 | AGN | Allergan plc | WALSH MATTHEW M | EVP, Chief Financia ... | Grant | A | 160.59 | 13,076 | 2,099,875 | 13,076 | 0 to 13.1 K |
Page: 1